Michael Fralick

Dr. Michael Fralick is an Associate Professor and a Clinician Scientist at Mount Sinai Hospital with specialization in General Internal Medicine. He completed his medical degree and internal medicine residency training at the University of Toronto, and a Master of Science in Clinical Epidemiology at Harvard University. His PhD, completed at the University of Toronto, focused on the intersection between supervised machine learning and pharmacoepidemiology.

During the COVID-19 pandemic, he shifted his research focus to pragmatic clinical trials to identify treatments for COVID-19. Many of these treatments subsequently became the standard of care for the management of patients hospitalized with COVID-19 globally. He also co-led environmental surveillance work for detecting SARS-CoV-2 from the built environment which was subsequently shown to predict outbreaks in hospitals and long-term care homes before they are clinically recognized. He is also a founding board member and deputy editor at the New England Journal of Medicine Evidence.